Candriam Equities L Biotechnology, N - Capitalisation/ LU0133359157 /
| NAV4/16/2025 | Chg.-8.0300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 531.4100USD | -1.49% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2002 | - | - | - | - | - | - | - | - | -9.99 | 9.27 | 2.64 | - | - |
| 2003 | - | - | - | - | - | -6.25 | 7.90 | -0.80 | -0.09 | 2.12 | -1.24 | 6.03 | - |
| 2004 | 5.42 | 4.81 | -3.06 | -0.68 | -2.96 | 0.28 | -9.15 | 2.14 | 5.72 | -2.18 | 0.74 | 6.05 | +6.15% |
| 2005 | -3.86 | -5.24 | -4.01 | 3.01 | 6.31 | 2.82 | 10.06 | 1.21 | 2.73 | -3.43 | 5.62 | 1.27 | +16.38% |
| 2006 | 5.99 | 3.91 | -3.59 | -4.80 | -4.48 | 0.06 | -2.53 | 2.54 | 0.15 | 13.69 | 0.72 | -2.30 | +8.18% |
| 2007 | 2.24 | -3.57 | 1.98 | 7.43 | 0.04 | -5.90 | -2.87 | 1.84 | 5.47 | 2.09 | -2.86 | -5.99 | -1.10% |
| 2008 | -5.07 | -3.48 | 1.48 | 1.37 | 1.61 | -2.78 | 16.97 | -4.30 | -6.61 | -15.68 | -10.20 | 8.00 | -20.40% |
| 2009 | -1.42 | -7.01 | 6.04 | -0.52 | 2.83 | 7.05 | 29.13 | 2.56 | 1.34 | -11.29 | 7.95 | 5.16 | +43.88% |
| 2010 | 3.23 | 6.29 | 14.90 | -2.05 | -12.53 | -5.77 | 3.59 | -0.52 | 10.67 | 2.64 | -2.62 | 6.14 | +23.13% |
| 2011 | -0.68 | 0.69 | 5.87 | 4.49 | 2.90 | -1.81 | -3.60 | -8.06 | -6.72 | 7.88 | 0.66 | 1.74 | +2.10% |
| 2012 | 11.78 | 0.35 | 5.71 | 0.51 | -2.19 | 5.47 | 2.29 | 1.87 | 5.11 | -6.00 | 4.35 | -1.07 | +30.67% |
| 2013 | 9.62 | 0.98 | 8.03 | 6.05 | 3.25 | -2.79 | 14.21 | -2.47 | 9.90 | -2.84 | 6.49 | 1.57 | +63.77% |
| 2014 | 8.21 | 7.30 | -9.98 | -5.14 | 2.72 | 10.07 | -3.28 | 11.02 | -1.15 | 9.55 | 2.94 | 0.54 | +34.91% |
| 2015 | 4.43 | 4.49 | 1.81 | -5.15 | 10.69 | 0.59 | 4.13 | -10.99 | -11.43 | 7.76 | 3.39 | 0.28 | +7.62% |
| 2016 | -23.27 | -4.63 | 3.63 | 3.65 | 5.55 | -8.45 | 12.52 | -2.43 | 3.93 | -12.76 | 9.07 | -2.88 | -19.92% |
| 2017 | 5.46 | 6.80 | 0.04 | 1.04 | -2.99 | 9.33 | 2.35 | 6.77 | 0.86 | -6.65 | 0.08 | 1.42 | +26.10% |
| 2018 | 6.65 | -4.65 | -2.19 | -3.25 | 4.56 | 0.76 | 4.36 | 4.08 | -2.13 | -14.06 | 4.08 | -8.36 | -11.63% |
| 2019 | 13.08 | 3.53 | -0.61 | -4.99 | -4.51 | 9.39 | -2.25 | -2.40 | -4.55 | 11.15 | 11.92 | 2.74 | +34.38% |
| 2020 | -5.32 | -1.57 | -5.04 | 12.31 | 9.44 | 1.23 | -3.05 | 0.79 | 0.67 | -2.70 | 9.40 | 2.93 | +18.68% |
| 2021 | 1.77 | -2.64 | -4.33 | 2.67 | -2.30 | 6.29 | -1.51 | 3.84 | -4.29 | 0.11 | -4.43 | 2.36 | -3.12% |
| 2022 | -10.62 | -1.60 | 5.99 | -7.27 | -4.02 | 3.46 | 4.67 | 1.48 | -1.95 | 6.45 | 6.13 | -2.90 | -1.94% |
| 2023 | 2.87 | -5.70 | 0.20 | 2.23 | -0.99 | 1.39 | -0.62 | -0.27 | -4.53 | -6.16 | 6.11 | 13.59 | +6.77% |
| 2024 | 1.44 | 1.31 | -0.07 | -6.29 | 3.78 | 5.61 | 6.30 | 1.70 | -2.45 | -1.56 | 0.41 | -7.06 | +2.18% |
| 2025 | 3.38 | -0.94 | -7.04 | -7.43 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 25.53% | 23.68% | 20.45% | 20.61% | 20.84% |
| Sharpe ratio | -1.47 | -1.75 | -0.41 | -0.11 | 0.00 |
| Best month | +3.38% | +3.38% | +6.30% | +13.59% | +13.59% |
| Worst month | -7.43% | -7.43% | -7.43% | -7.43% | -10.62% |
| Maximum loss | -21.45% | -26.52% | -26.52% | -26.52% | -31.06% |
| Outperformance | -6.86% | - | -1.46% | -7.50% | -4.10% |
All quotes in USD
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 1,804.9399 | -7.15% | -5.28% | |
| Candriam Equities L Biotechnolog... | reinvestment | 1,883.4399 | -11.40% | -2.95% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,909.1799 | -10.96% | +0.22% | |
| Candriam Equities L Biotechnolog... | reinvestment | 1,656.5800 | -4.77% | +4.45% | |
| Candriam Equities L Biotechnolog... | reinvestment | 186.1200 | -12.09% | -4.37% | |
| Candriam Equities L Biotechnolog... | reinvestment | 306.7800 | -10.84% | +1.60% | |
| Candriam Equities L Biotechnolog... | reinvestment | 276.9000 | -11.28% | -1.75% | |
| Candriam Equities L Biotechnolog... | reinvestment | 172.9900 | -9.23% | -9.27% | |
| Candriam Equities L Biotechnolog... | reinvestment | 129.8800 | -8.15% | - | |
| Candriam Equities L Biotechnolog... | reinvestment | 5,029.8901 | -5.12% | +2.38% | |
| Candriam Equities L Biotechnolog... | reinvestment | 1,840.2900 | -5.02% | +2.83% | |
| Candriam Equities L Biotechnolog... | reinvestment | 531.4100 | -6.18% | -0.11% | |
| Candriam Equities L Biotechnolog... | reinvestment | 172.1300 | -7.82% | -5.88% | |
| Candriam Equities L Biotechnolog... | reinvestment | 239.6200 | -4.99% | +3.70% | |
| Candriam Equities L Biotechnolog... | reinvestment | 180.8500 | -7.05% | -4.04% | |
| Candriam Equities L Biotechnolog... | reinvestment | 748.4300 | -5.83% | +1.06% | |
| Candriam Equities L Biotechnolog... | paying dividend | 683.3400 | -5.86% | +0.97% |
Performance
| YTD | -11.88% | ||
|---|---|---|---|
| 6 Months | -21.99% | ||
| 1 Year | -6.18% | ||
| 3 Years | -0.11% | ||
| 5 Years | +11.94% | ||
| 10 Years | +20.36% | ||
| Since start | +662.10% | ||
| Year | |||
| 2024 | +2.18% | ||
| 2023 | +6.77% | ||
| 2022 | -1.94% | ||
| 2021 | -3.12% | ||
| 2020 | +18.68% | ||
| 2019 | +34.38% | ||
| 2018 | -11.63% | ||
| 2017 | +26.10% | ||
| 2016 | -19.92% | ||
